Core Insights - Over 20 drugs are expected to participate in the price negotiation for the commercial insurance innovative drug catalog this year [1] - The price negotiation will take place from this afternoon until tomorrow, with around ten pharmaceutical companies already present [1] Group 1: Participating Companies - BeiGene is bringing multiple drugs to the negotiation, including injection drugs such as Zhenidamab, Dato-DXd injection, and Belantamab Mafodotin [1] - Belantamab Mafodotin is included in both commercial insurance and medical insurance negotiations [1] - Five major CAR-T product companies, along with companies like Green Leaf Pharmaceutical and New Era Pharmaceutical, are also participating in the negotiation [1]